Literature DB >> 2904883

Effect of calcium channel blockade and beta-adrenoceptor blockade on short graded and single-level endurance exercises in normal men.

L Vanhees1, R Fagard, A Amery.   

Abstract

The effect of verapamil (240 mg) on exercise capacity was studied during a short graded and a single-level endurance exercise test in 12 normal volunteers; it was compared to the effects of atenolol (100 mg x day-1). Intake of verapamil, atenolol and placebo, administered according to a randomized, double-blind cross-over design, was started 3 days before the exercise tests. Compared to placebo, verapamil did not affect peak oxygen uptake in the graded test or exercise duration in the endurance test. Heart rate, systolic blood pressure, rating of perceived exertion and respiratory data at submaximal and peak exercise were unaffected in either test. On the other hand atenolol reduced maximal oxygen uptake by 5% (p less than 0.001) and endurance exercise duration by 17% (p less than 0.05). Besides marked decreases in heart rate and systolic blood pressure during the two types of exercise, atenolol also reduced oxygen uptake at submaximal exercise levels and it increased the rating of perceived exertion (p less than 0.05), the latter only during the endurance exercise test.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2904883     DOI: 10.1007/BF00636608

Source DB:  PubMed          Journal:  Eur J Appl Physiol Occup Physiol        ISSN: 0301-5548


  24 in total

1.  Effects of cardioselective and nonselective beta-blockade on dynamic exercise performance in mildly hypertensive men.

Authors:  F H Leenen; C H Coenen; M Zonderland; A H Maas
Journal:  Clin Pharmacol Ther       Date:  1980-07       Impact factor: 6.875

2.  Effect of beta-adrenoceptor blockade on exercise performance and metabolism.

Authors:  P Lundborg; H Aström; C Bengtsson; E Fellenius; H von Schenck; L Svensson; U Smith
Journal:  Clin Sci (Lond)       Date:  1981-09       Impact factor: 6.124

3.  Glucose-induced decrease in glucagon and pinephrine responses to exercise in man.

Authors:  H Galbo; N J Christensen; J J Holst
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1977-04

4.  Differentiation of exercise-induced metabolic responses during selective beta 1- and beta 2-antagonism.

Authors:  P Hespel; P Lijnen; L Vanhees; R Fagard; R Fiocchi; E Moerman; A Amery
Journal:  Med Sci Sports Exerc       Date:  1986-04       Impact factor: 5.411

5.  Hemodynamic effects of calcium channel blockers at rest and during exercise in essential hypertension.

Authors:  P Lund-Johansen
Journal:  Am J Med       Date:  1985-10-11       Impact factor: 4.965

6.  Hemodynamic response to graded exercise after chronic beta-adrenergic blockade.

Authors:  T Reybrouck; A Amery; L Billiet
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1977-02

7.  Effects of diltiazem on serum lipids, exercise performance and blood pressure: randomized, double-blind, placebo-controlled evaluation for systemic hypertension.

Authors:  P E Pool; S C Seagren; A F Salel
Journal:  Am J Cardiol       Date:  1985-12-06       Impact factor: 2.778

8.  Intrinsic and reflex actions of verapamil and nifedipine: assessment in normal subjects by noninvasive techniques and autonomic blockade.

Authors:  H C Stern; J H Matthews; G G Belz
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

9.  Regular formulation and sustained-release verapamil therapy in normotension and in mild to moderate hypertension.

Authors:  M D Klein; D A Weiner; M A Kellett
Journal:  Am J Cardiol       Date:  1986-02-26       Impact factor: 2.778

10.  Effects of beta-adrenergic blockade on O2 uptake during submaximal and maximal exercise.

Authors:  P A Tesch; P Kaiser
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1983-04
View more
  6 in total

1.  The effects of beta1-adrenergic blockade on cardiovascular oxygen flow in normoxic and hypoxic humans at exercise.

Authors:  Guido Ferretti; Marc J Licker; Sara Anchisi; Christian Moia; Davide Susta; Denis R Morel
Journal:  Eur J Appl Physiol       Date:  2005-10-01       Impact factor: 3.078

Review 2.  Influence of antihypertensive drugs on exercise capacity.

Authors:  R Fagard; J Staessen; L Thijs; A Amery
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 3.  Beta-adrenoceptor blockade and exercise. An update.

Authors:  M A Van Baak
Journal:  Sports Med       Date:  1988-04       Impact factor: 11.136

4.  Functional capacity in healthy volunteers before and following beta-blockade with controlled-release metoprolol.

Authors:  P K Rønnevik; J E Nordrehaug; G von der Lippe
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

Review 5.  Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  D McTavish; E M Sorkin
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

6.  A Randomized Controlled Trial of R-Form Verapamil Added to Ongoing Metformin Therapy in Patients with Type 2 Diabetes.

Authors:  Chih-Yuan Wang; Kuo-Chin Huang; Chia-Wen Lu; Chih-Hsun Chu; Chien-Ning Huang; Harn-Shen Chen; I-Te Lee; Jung-Fu Chen; Ching-Chu Chen; Chung-Sen Chen; Chang-Hsun Hsieh; Kai-Jen Tien; Hung-Yu Chien; Yu-Yao Huang; Jui-Pao Hsu; Guang-Tzuu Shane; Ai-Ching Chang; Yen-Chieh Wu; Wayne Huey-Herng Sheu
Journal:  J Clin Endocrinol Metab       Date:  2022-09-28       Impact factor: 6.134

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.